Wednesday, December 17


CALeDNA program assesses biodiversity in California soil

Volunteers throughout California are heeding a call by UCLA researchers to map California’s biodiversity and preserve the state’s environmental history. The project, CALeDNA, aims to assess Californian biodiversity across numerous habitats using soil samples collected by citizen scientists. Read more...

Photo: Volunteers have gathered more than 400 soil samples for CALeDNA, a new program that aims to use DNA sequencing to map the distribution of species across California. (Courtesy of Emily Curd)


Alumnus Meyer Luskin donates $5M to fund center for history, policy

UCLA received a $5 million donation Wednesday to establish a center to apply historical research to modern-day problems. Alumnus Meyer Luskin, one of the namesakes of the Luskin School of Public Affairs, stipulated his gift would fund the Luskin Center for History and Policy, which will have the mission of furthering the study of historical events and how that knowledge is useful in creating effective public policy. Read more...

Photo: Meyer Luskin donated $5 million to establish a new Center for History and Policy, which will apply historical research to modern-day problems. (UCLA Newsroom)


CDC acting director talks preventing disease breakouts at Burkle event

UCLA students, faculty and physicians learned more about measures in the international health community that aim to prevent major disease breakouts at an event Monday night. Read more...

Photo: Dr. Anne Schuchat, acting director of the Centers for Disease Control and Prevention, shared her experiences tackling global health crises at UCLA Ronald Reagan Medical Center on Monday evening. (Amy Dixon/Daily Bruin)


UCLA researchers explore treatment for unresponsive skin cancer

A drug previously found to successfully treat several types of skin cancers is actually not effective for people with certain skin cancers, UCLA researchers found last week. Read more...

Photo: UCLA Jonnson Comprehensive Cancer Center researchers are developing alternative treatments for patients with genetic mutations that do not respond to current immunotherapies for their cancers. (Courtesy of Antoni Ribas)





1 179 180 181 182 183 336